$1.5 million is the 'magic number' for retirement savings—here's how long it lasts in every U.S. state ...

Whether they’re suffering from red, itchy eyes during allergy season, dealing with the discomfort of ear wax buildup or ...

Dan Gandor, an omnichannel ace who has spent his entire career on the client side of the business, has joined Eversana ...

An AbbVie drug gives patients a new choice as the ... Approval of the drug, telisotuzumab vedotin, brand name Emrelis, covers the treatment of non-squamous NSCLC that is locally advanced or ...

The Newport Beach aesthetics company launched Evolysse Form and Evolysse Smooth, which refers to its injectable hyaluronic ...

AbbVie ABBV announced that the FDA has granted ... The drug will be marketed under the brand name Emrelis. Under this approval, Emrelis is approved to treat adult patients with locally advanced ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), ...

The long-term accommodations sector shows promise for stable growth amid rockier economic times, Choice’s CEO shared during a ...

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some of the most expensive medications.

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

CollPlant Biotechnologies , a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and ...